{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:56:53Z","timestamp":1747169813043,"version":"3.40.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pupt.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T06:44:19Z","timestamp":1455950659000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of low- versus high-dose fluticasone propionate\/formoterol fumarate combination therapy on AMP challenge in asthmatic patients: A double-blind, randomised clinical trial"],"prefix":"10.1016","volume":"37","author":[{"given":"Frank","family":"Kanniess","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Diamant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0454-6962","authenticated-orcid":false,"given":"Mark","family":"Lomax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pupt.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1183\/09031936.02.00283202","article-title":"Scientific rationale for inhaled combination therapy with long-acting \u03b22-agonists and corticosteroids","volume":"19","author":"Barnes","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.0306-5251.2001.01493.x","article-title":"Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler\u00ae","volume":"52","author":"Thorsson","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.pupt.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s002280050407","article-title":"Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration","volume":"53","author":"M\u00f6llmann","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000024371","article-title":"Binding of glucocorticoids to human nasal tissue in\u00a0vitro","volume":"122","author":"Esmailpour","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"10","key":"10.1016\/j.pupt.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1365-2222.2009.03306.x","article-title":"Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex\u00a0vivo","volume":"39","author":"Baumann","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1124\/dmd.112.046318","article-title":"Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes","volume":"41","author":"Moore","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.112.202556","article-title":"Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymes","volume":"345","author":"Roberts","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.102.038208","article-title":"Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells","volume":"304","author":"Hukkanen","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.pupt.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1476-5381.2012.01864.x","article-title":"Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition","volume":"167","author":"Rossios","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2007.08.034","article-title":"The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells","volume":"120","author":"Horvath","year":"2007","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.pupt.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.109.156224","article-title":"Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea","volume":"333","author":"Adner","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pupt.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pupt.2015.10.001","article-title":"An evaluation of comparative treatment effects with high and low dose fluticasone propionate\/formoterol fumarate combination in asthma","volume":"35","author":"Dissanayake","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.pupt.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1183\/09031936.00022010","article-title":"Comparison of two twice-daily doses of budesonide\/formoterol maintenance and reliever therapy","volume":"36","author":"Aubier","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.pupt.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1164\/ajrccm.164.8.2104102","article-title":"Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial","volume":"164","author":"O'Byrne","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"20","key":"10.1016\/j.pupt.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group","volume":"337","author":"Pauwels","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1183\/09031936.99.14510389","article-title":"Asthma quality of life during 1 year of treatment with budesonide with or without formoterol","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2500\/aap.2008.29.3147","article-title":"Long-term safety and asthma control with budesonide\/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients","volume":"29","author":"Peters","year":"2008","journal-title":"Allergy Asthma Proc."},{"issue":"4","key":"10.1016\/j.pupt.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2500\/aap.2010.31.3381","article-title":"Study Investigators of P04431. Twelve-week efficacy and safety study of mometasone furoate\/formoterol 200\/10 microg and 400\/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids","volume":"31","author":"Weinstein","year":"2010","journal-title":"Allergy Asthma Proc."},{"issue":"7","key":"10.1016\/j.pupt.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1164\/ajrccm.164.7.2102135","article-title":"Corticosteroid-induced improvement in the PC20 of adenosine 5\u2032-monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine","volume":"164","author":"Van den Berge","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.pupt.2016.02.003_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1164\/ajrccm.160.1.9809046","article-title":"A\u00a0dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5\u2032-monophosphate in asthmatic patients","volume":"160","author":"Taylor","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.pupt.2016.02.003_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.54.10.894","article-title":"Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma","volume":"54","author":"Meijer","year":"1999","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pupt.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1378\/chest.118.4.1049","article-title":"Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults","volume":"118","author":"Aziz","year":"2000","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1081-1206(10)62140-0","article-title":"Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis","volume":"90","author":"Currie","year":"2003","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.pupt.2016.02.003_bib24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.02.00285302","article-title":"Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship","volume":"20","author":"Jones","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.pupt.2016.02.003_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/thorax.57.10.889","article-title":"Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma","volume":"57","author":"Kharitonov","year":"2002","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/thx.54.2.108","article-title":"Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma","volume":"54","author":"Jatakanon","year":"1999","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib27","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1378\/chest.119.5.1322","article-title":"Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients","volume":"119","author":"Silkoff","year":"2001","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2006.01.045","article-title":"Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids","volume":"117","author":"Kelly","year":"2006","journal-title":"J\u00a0Allerg. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.pupt.2016.02.003_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thx.2010.135574","article-title":"A\u00a0systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)","volume":"67","author":"Petsky","year":"2012","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1067\/mai.2000.105709","article-title":"Mometasone furoate antagonizes AMP induced bronchoconstriction in patients with mild asthma","volume":"105","author":"Holgate","year":"2000","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.pupt.2016.02.003_bib31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide","volume":"171","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1378\/chest.06-1335","article-title":"Portable exhaled nitric oxide measurement: comparison with the \u201cgold standard\u201d technique","volume":"131","author":"Menzies","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry. ATS\/ERS task force: standardisation of lung function testing. series No 2. edited by Brusasco V, Crapo R, and Viegi G.","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"Suppl 16","key":"10.1016\/j.pupt.2016.02.003_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society","volume":"6","author":"Quanjer","year":"1993","journal-title":"Eur. Respir. J."},{"issue":"Suppl 16","key":"10.1016\/j.pupt.2016.02.003_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/09041950.053s1693","article-title":"Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults","volume":"6","author":"Sterk","year":"1993","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2016.02.003_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2466-11-60","article-title":"Rapid effects of extrafine beclomethasone dipropionate\/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial","volume":"11","author":"O'Connor","year":"2011","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.pupt.2016.02.003_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1365-2222.1998.00243.x","article-title":"Changes in sputum composition during sputum induction in healthy and asthmatic patients","volume":"28","author":"Holz","year":"1998","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.pupt.2016.02.003_bib38","first-page":"9S","article-title":"Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma","volume":"26","author":"Kips","year":"1998","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.pupt.2016.02.003_bib39","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.rmed.2009.01.024","article-title":"Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering","volume":"103","author":"van den Berge","year":"2009","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.pupt.2016.02.003_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/pupt.2001.0288","article-title":"Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma","volume":"14","author":"Kanniess","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.pupt.2016.02.003_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1183\/09031936.98.12030580","article-title":"Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol","volume":"12","author":"Aziz","year":"1998","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.pupt.2016.02.003_bib42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1067\/mai.2002.128486","article-title":"Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5-monophosphate in mild asthma","volume":"110","author":"Ketchell","year":"2002","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.pupt.2016.02.003_bib43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1183\/09031936.02.00332001","article-title":"Dose-related effects of formoterol on airway responsiveness to adenosine 5-monophosphate and histamine","volume":"19","author":"Ketchell","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.rmed.2013.02.010","article-title":"Dose-dependent anti-inflammatory effect of inhaled Mometasone furoate\/formoterol in patients with asthma","volume":"107","author":"Nolte","year":"2013","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.pupt.2016.02.003_bib45","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.pupt.2016.02.003_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9343(99)00435-0","article-title":"Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma","volume":"108","author":"Wilson","year":"2000","journal-title":"Am. J. Med."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553916300086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553916300086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T21:27:13Z","timestamp":1536960433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553916300086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":46,"alternative-id":["S1094553916300086"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2016.02.003","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of low- versus high-dose fluticasone propionate\/formoterol fumarate combination therapy on AMP challenge in asthmatic patients: A double-blind, randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}